Navigation Links
Americans Deficient In Dietary Intake Of Choline Needed for Fetal Brain Development

Women in US are not getting ample amounts of a nutrient that is essential for the promotion of normal fetal brain development.//

A new study sponsored by the National Institute of Health, that has been conducted by three of the top universities in America has suggested that the women in US aren’t getting sufficient amounts of a nutrient, which is required to promote normal fetal brain development.

According to the government health officials ‘Choline’, which is a nutrient essential for human brain development, normal memory function, fertility, and, which is thought to be particularly important during pregnancy, is required to be consumed as 425 milligrams for women and 550 milligrams men daily. But the researchers found in their study that an average American consumes just 314 milligrams of choline each day that is far less than the amount recommended.

Soy lecithin, beef liver and egg yolks, are some of the foodstuffs that are rich in choline. Soy lecithin is also considered as one of the most bioactive and natural sources of the nutrient, which has no cholesterol or saturated fat.

The researchers had explained that they faced difficulty in accurately estimating the per capita choline intake, as the food composition database was only recently made available to the research community. The researchers explained in their research to have studied the diets of around 2,000 subjects by comparing them with the data from a food frequency questionnaire against a new choline database by the U.S. Department of Agriculture.

Steven H. Zeisel, M.D., one of the researchers, said, “Our research suggests the typical American diet is lower in choline than recommended.” He further added “When corrected for energy intake, daily choline levels were significantly below the recommended daily intake for both men and women. Although we cannot be sure from this study, Americans may not understand the importance of choline in their
'"/>




Page: 1 2 3

Related medicine news :

1. Poll Finds Many Americans Misinformed About Cancer
2. Poll Finds Many Americans Misinformed About Cancer
3. Hypertension Drug of Choice for African Americans
4. 38 million Americans including 14 million children left to combat hunger
5. Americans Consume Far Too Much Salt and Sodium
6. Americans Growing Out Of Shape
7. Rise in Stress among Americans
8. Home Remedies More Used By Blacks And Native Americans
9. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
10. Aspirin, Not Used By African Americans And Diabetics To Prevent Heat Problems
11. Americans Not Interested In Choosing Sex Of Child: Survey
Post Your Comments:
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
...ing to a recent study by psychologists at the Univ...babies is notably more acceptable to the learned t...sented the findings at the BA Festival of Science ...nce, what would different groups of people in the ...
...y College Dublin has joined hands with Florida-bas...od pressure drug Nilvadipine and its possible use ...arch Network (DARN). Doctors of Geriatrics and Old...l, Beaumont Hospital, James Connolly Memorial Hosp...
... student in Orissa's Bhadrak district now has hope...A.P.J. Abdul Kalam intervened //in his struggle to...of Bhadrak town, secured the first position in his... to get admission at the National Institute of Soc...
...Pradesh Family Welfare Minister Ahmad Hasan Friday...e state in tackling the disease among children.// ... vaccine, otherwise there is no reason why it shou...many cases. "Hasan told reporters here. "After al...
Other Medicine News:Health News:Designer babies 2
(Date:9/4/2008)...tion for Targeted Therapies That Ensu...N BEACH, Calif., and AMSTERDAM, Netherlands, Sept....cular cancer diagnostics,today announced the laun...llows physicians to quantitatively determine the g...), progesterone receptor (PR) and Human Epidermal,...
(Date:9/3/2008)...irstCall/ -- Simcere,Pharmaceutical Group (NYSE: ...ded generic pharmaceuticals and manufacturer of th...known as Endostar) in China,announced the interim... request of the SFDA, Simcere initiated a Phase IV... therapeutic efficacy of Endu, a modified,version ...
(Date:9/3/2008)... /- Artelis SA and,Selexis SA announc...ntibody,production with the achievement of manufac...ord level was accomplished by applying two highly,...able Selexis CHO,production cell line rapidly gene... using their proprietary Selexis Genetic Elements(...
(Date:9/3/2008)...ingo Launch Progress and Adlea ...ence Call Today at 11:30 am ET, SOUTH SAN FRANCIS...iva,Inc. (Nasdaq: ANSV ) announced today that th...commercial and late-stage product development to,a...ical pain management,company. The company also pro...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Iowa State researcher studies how enzymes break down cellulose 2066 1Iowa State researcher studies how enzymes break down cellulose 2066 2American College of Preventive Medicine calls on ABC to cancel Eli Stone episode 10551 1SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services 10547 1SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services 10547 2SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services 10547 3Drug Related Images Trigger Brains Reward Center 10545 1Drug Related Images Trigger Brains Reward Center 10545 2
...26, 2007 /PRNewswire-FirstCall/ --,Replidyne, Inc....,studying REP8839, a novel topical antibiotic that...skin pathogens including,methicillin-resistant S. ...how that topically applied REP8839 appears safe,w...osure, or drug,absorption into the bloodstream, wh...
...-Jun 25, 2007 - New data from an,investigational s...,(ADA) 67th Annual Scientific Sessions showed that...agliptin) and metformin,demonstrated significant i...ients with type 2 diabetes. Pancreatic islet beta,...o produce,insulin, a hormone which plays a central...
Other Medicine Technology:Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 2Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 3Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 4An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 2An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 3An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 4An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 5An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 6An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 7An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 8An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 9An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 10An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 11An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 12An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 13An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 14An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 15An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 16An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 17An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 18An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 19An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 20An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 21An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 22An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 23An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 24An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 25An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 26An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 27An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 28An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 29An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 30An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 31An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 32
The Explorer 360 and 360 Jr. catheters have a rotational connector for ease of use during procedures.
...of the PARAHISIAN catheter, combines an octapolar ...es, which permits the use of only one catheter for...is bundle electrograms. The "two catheters in one"...single venipuncture. The disadvantages of using tw...
Torqr Quadripolar Braided Shaft Fixed Curve. The Medtronic CardioRhythm Torqr Catheter is intended for use in diagnostic electrophysiologic procedures. The catheter is designed for recording intrac
Xtrem Dynamic is a line of steerable diagnosis catheters with micro handle. These catheters have been designed to provide pacing and recording during invasive electrophysiology procedures.
Medicine Products: